Preferred Label : cinnarizine;

MeSH definition : A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.;

MeSH synonym : 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine; cinarizine;

CISMeF synonym : ct-Arzneimittel brand of cinnarizine; aliud brand of cinnarizine; alpharma brand of cinnarizine; artu brand of cinnarizine; kendrick brand of cinnarizine; esteve brand of cinnarizine; janssen brand of cinnarizine; inkeysa brand of cinnarizine; ratiopharm brand of cinnarizine; ashbourne brand of cinnarizine;

CISMeF acronym : R516;

DeCS synonym : Cinnarizin Ratiopharm; Cinazi re; R516;

MeSH hyponym : stugeron; cinna; cinnarizine L-Tartrate; cinarizina ratiopharm; cinnarizine, (E)-Isomer; cinazière; cinarizina inkey; cinnarizine L-Tartrate (1:1); cinnarizin AL; cinnarizin siegfried; dimitronal; cinnipirine; cinnarizine, dihydrochloride; R-516; cisaken; Cinnarizin-Ratiopharm; Cinnarizin Ratiopharm; Cinnarizin Von Ct; Von Ct, Cinnarizin; Cinnarizine L Tartrate; L-Tartrate, Cinnarizine; Dihydrochloride Cinnarizine; R 516; R516; Stugeron Forte;

MeSH CAS label : piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-;

MeSH Related Number : cinnarizine, (E)-Isomer; cinnarizine L-Tartrate; cinnarizine L-Tartrate (1:1); cinnarizine, dihydrochloride; 16699-20-0 ((E)-isomer); 298-57-7 (Cinnarizine); 60145-68-8 (L-tartrate); 7002-58-6 (di-HCl); 86349-62-4 (L-tartrate (1:1));

Registry Number MeSH : 298-57-7;

Related CAS MeSH : 16699-20-0 (Cinnarizine, (E)-Isomer); 60145-68-8 (Cinnarizine L-Tartrate); 86349-62-4 (Cinnarizine L-Tartrate (1:1)); 7002-58-6 (Cinnarizine, dihydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Cinnarizine;

Codes EINECS : 206-064-8;

Is substance : O;

UNII : 3DI2E1X18L;

InChIKey : DERZBLKQOCDDDZ-JLHYYAGUSA-N;

Details


Main resources

You can consult :

A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.

http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/03vol29/acs-dcc-11/index_f.html
http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/03vol29/acs-dcc-11/index.html
2003
Canada
French
English
travel medicine
motion sickness
motion sickness
signs and symptoms
risk factors
motion sickness
incidence
motion sickness
diagnosis, differential
motion sickness
motion sickness
dextroamphetamine
dextroamphetamine
adrenergic uptake inhibitors
adrenergic uptake inhibitors
cinnarizine
cinnarizine
cyclizine
dimenhydrinate
dimenhydrinate
meclizine
promethazine
promethazine
Scopolamine
canada
united states
travel
cyclizine
dimenhydrinate
meclizine
Scopolamine
adrenergic uptake inhibitors
antiemetics
antiemetics
cyclizine
meclizine
Scopolamine
cinnarizine
promethazine
antiemetics
Evidence-Based medicine
journal article
guidelines

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.